Stockscreener 앱 받기
24.98
21.68%
4.45
시간 외 거래:
24.26
-0.72
-2.88%
전일 마감가:
$20.53
열려 있는:
$20.6
하루 거래량:
480.51K
Relative Volume:
1.62
시가총액:
$346.09M
수익:
-
순이익/손실:
$-8.89M
주가수익비율:
-35.69
EPS:
-0.7
순현금흐름:
$-6.48M
1주 성능:
+18.90%
1개월 성능:
+179.42%
6개월 성능:
+148.06%
1년 성능:
+80.88%
1일 변동 폭
$20.40
$25.20
1주일 범위
$18.54
$25.20
52주 변동 폭
$7.78
$30.82
그리니치 Stock (GLSI) Company Profile
명칭
Greenwich Lifesciences Inc
전화
203-434-3290
주소
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
GLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
24.98 | 284.43M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
그리니치 Stock (GLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 개시 | Noble Capital Markets | Outperform |
| 2021-09-01 | 개시 | H.C. Wainwright | Buy |
그리니치 주식(GLSI)의 최신 뉴스
Why Greenwich LifeSciences Inc. stock is a must watch in 2025Volume Weighted Average Price & Smart Beta Strategies That Actually Work - ulpravda.ru
How $594B in Precision Tech is Cracking the Metastatic Cancer Code - The Globe and Mail
Snehal Patel Buys Handful Of Shares In Greenwich LifeSciences - simplywall.st
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Acquires 4,300 Shares - Defense World
A US$74m drop in the market cap of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is not what insiders like to see after purchasing shares recently - simplywall.st
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Acquires 4,300 Shares of Stock - MarketBeat
Head-To-Head Analysis: Greenwich LifeSciences (NASDAQ:GLSI) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Snehal Patel Purchases 2,900 Shares of Greenwich LifeSciences (NASDAQ:GLSI) Stock - Defense World
Is Lehar Footwears Limited Poised for a PostEarnings RallyVolatility Adjusted Trading & Free Exceptional Risk Adjusted Gains - earlytimes.in
Insider Buying: Snehal Patel Acquires Additional Shares of Green - GuruFocus
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock By Investing.com - Investing.com Canada
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Buys 2,900 Shares - MarketBeat
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock - Investing.com
FY2025 Earnings Estimate for GLSI Issued By HC Wainwright - MarketBeat
How (GLSI) Movements Inform Risk Allocation Models - Stock Traders Daily
New milestone in breast cancer prevention claimed by Greenwich - The Pharma Letter
Greenwich LifeSciences extends insider share lock-up to Sept 2026 By Investing.com - Investing.com Nigeria
Greenwich LifeSciences stock soars after extending insider lock-up By Investing.com - Investing.com South Africa
Greenwich LifeSciences stock soars after extending insider lock-up - Investing.com India
What's Going On With Greenwich LifeSciences Stock Monday? - One News Page
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Greenwich LifeSciences Takes Flight As FLAMINGO 01 Breast Cancer Trial Progresses - Nasdaq
Why Did GLSI Stock Surge 25% Today? - Stocktwits
Greenwich LifeSciences extends lock-up of shares to September 2026 - marketscreener.com
Greenwich LifeSciences Extends Lock-Up Of Shares To September 2026 - TradingView — Track All Markets
Greenwich LifeSciences Extends Share Lock-Up to September For Directors, Officers - marketscreener.com
Greenwich LifeSciences extends insider share lock-up to Sept 2026 - Investing.com
Greenwich LifeSciences, Inc. Announces Extension of Lock-Up Period for Shares to September 30, 2026 - Quiver Quantitative
Biotech locks insiders out of selling stock for six years to back cancer trial - Stock Titan
Greenwich LifeSciences (NASDAQ:GLSI) Raised to "Hold" at Wall Street Zen - MarketBeat
Greenwich LifeSciences (NASDAQ:GLSI) Raised to “Hold” at Wall Street Zen - Defense World
What's Going On With Greenwich LifeSciences Friday? - Sahm
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy - Sahm
Greenwich LifeSciences provides updates on Phase III breast cancer trial By Investing.com - Investing.com Nigeria
Greenwich Life Sciences Provides Updates On Breast Cancer Study; Outlines Corporate Strategy - Nasdaq
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters - TipRanks
Greenwich LifeSciences provides updates on Phase III breast cancer trial - Investing.com
Greenwich LifeSciences Provides Updates on Phase III FLAMINGO-01 Clinical Trial and Corporate Strategy - Quiver Quantitative
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Buys $51,742.00 in Stock - Defense World
How strong is Greenwich LifeSciences Inc. stock revenue growth2025 Retail Activity & Fast Gaining Stock Strategy Reports - bolumsonucanavari.com
(GLSI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Aug PreEarnings: Will Greenwich LifeSciences Inc. stock maintain momentum in 2025 - Улправда
Will Greenwich LifeSciences Inc. stock maintain momentum in 2025July 2025 Sector Moves & Capital Efficiency Focused Strategies - Улправда
Noble Financial Sticks to Their Buy Rating for Greenwich LifeSciences (GLSI) - The Globe and Mail
Is Greenwich LifeSciences Inc. stock positioned well for digital economyQuarterly Earnings Report & Technical Pattern Based Signals - Улправда
Insider Buying: Greenwich LifeSciences (NASDAQ:GLSI) CEO Purchases 4,100 Shares of Stock - MarketBeat
Will Greenwich LifeSciences Inc. stock outperform growth indexes2025 Trading Volume Trends & Low Volatility Stock Recommendations - DonanımHaber
Will Greenwich LifeSciences Inc. stock benefit from upcoming earnings reports2025 Bull vs Bear & Free Low Drawdown Momentum Trade Ideas - Улправда
그리니치 (GLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):